rabbit anti s100a10 Search Results


rabbit anti s100a10  (Huabio Inc)
90
Huabio Inc rabbit anti s100a10
OXA affects the activation of hippocampal type A1/A2 reactive astrocytes. OXA treatment decreases the number of type A1 astrocytes and increases the number of type A2 astrocytes. (A) Representative immunofluorescence images showing the co‐localization of GFAP‐labeled astrocytes with c3‐labeled A1 astrocytes and the co‐localization of GFAP‐labeled astrocytes with <t>S100A10‐labeled</t> A2 astrocytes co‐localized in the hippocampus. Scale bar = 20 μm. (B) Percentage of c3‐positive cells in the hippocampus that are GFAP‐positive. (C) Percentage of S100A10 positive cells in the hippocampal region that are GFAP positive. One‐way ANOVA and Tukey's post hoc test were used. The values were presented as mean ± SD (* p < 0.05, ** p < 0.01, # p < 0.0001, n = 3 for each group).
Rabbit Anti S100a10, supplied by Huabio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti s100a10/product/Huabio Inc
Average 90 stars, based on 1 article reviews
rabbit anti s100a10 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
rabbit anti-rat s100a10  (PeproTech)
90
PeproTech rabbit anti-rat s100a10
OXA affects the activation of hippocampal type A1/A2 reactive astrocytes. OXA treatment decreases the number of type A1 astrocytes and increases the number of type A2 astrocytes. (A) Representative immunofluorescence images showing the co‐localization of GFAP‐labeled astrocytes with c3‐labeled A1 astrocytes and the co‐localization of GFAP‐labeled astrocytes with <t>S100A10‐labeled</t> A2 astrocytes co‐localized in the hippocampus. Scale bar = 20 μm. (B) Percentage of c3‐positive cells in the hippocampus that are GFAP‐positive. (C) Percentage of S100A10 positive cells in the hippocampal region that are GFAP positive. One‐way ANOVA and Tukey's post hoc test were used. The values were presented as mean ± SD (* p < 0.05, ** p < 0.01, # p < 0.0001, n = 3 for each group).
Rabbit Anti Rat S100a10, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti-rat s100a10/product/PeproTech
Average 90 stars, based on 1 article reviews
rabbit anti-rat s100a10 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


OXA affects the activation of hippocampal type A1/A2 reactive astrocytes. OXA treatment decreases the number of type A1 astrocytes and increases the number of type A2 astrocytes. (A) Representative immunofluorescence images showing the co‐localization of GFAP‐labeled astrocytes with c3‐labeled A1 astrocytes and the co‐localization of GFAP‐labeled astrocytes with S100A10‐labeled A2 astrocytes co‐localized in the hippocampus. Scale bar = 20 μm. (B) Percentage of c3‐positive cells in the hippocampus that are GFAP‐positive. (C) Percentage of S100A10 positive cells in the hippocampal region that are GFAP positive. One‐way ANOVA and Tukey's post hoc test were used. The values were presented as mean ± SD (* p < 0.05, ** p < 0.01, # p < 0.0001, n = 3 for each group).

Journal: CNS Neuroscience & Therapeutics

Article Title: Orexin‐A Attenuates the Inflammatory Response in Sepsis‐Associated Encephalopathy by Modulating Oxidative Stress and Inhibiting the ERK / NF ‐ κB Signaling Pathway in Microglia and Astrocytes

doi: 10.1111/cns.70096

Figure Lengend Snippet: OXA affects the activation of hippocampal type A1/A2 reactive astrocytes. OXA treatment decreases the number of type A1 astrocytes and increases the number of type A2 astrocytes. (A) Representative immunofluorescence images showing the co‐localization of GFAP‐labeled astrocytes with c3‐labeled A1 astrocytes and the co‐localization of GFAP‐labeled astrocytes with S100A10‐labeled A2 astrocytes co‐localized in the hippocampus. Scale bar = 20 μm. (B) Percentage of c3‐positive cells in the hippocampus that are GFAP‐positive. (C) Percentage of S100A10 positive cells in the hippocampal region that are GFAP positive. One‐way ANOVA and Tukey's post hoc test were used. The values were presented as mean ± SD (* p < 0.05, ** p < 0.01, # p < 0.0001, n = 3 for each group).

Article Snippet: The primary antibodies used were: mouse anti‐Iba‐1 (GB123502‐100, Servicebio), mouse anti‐GFAP (#3670, Cell Signaling Technology), rabbit anti‐Iba‐1 (EPR16588, Abcam), rabbit anti‐P‐ERK (#9926, Cell Signaling Technology), rabbit anti‐NF‐κB (SZ10‐04, HuaBio), rabbit anti‐C3 (ET1702‐99, HuaBio), rabbit anti‐S100A10 (ET1702‐38, HuaBio), and rabbit anti‐Neun (#24307, Cell Signaling Technology).

Techniques: Activation Assay, Immunofluorescence, Labeling